Literature DB >> 21492226

Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.

Baoleri Lee1, Charlotte K Schjerling, Nikolai Kirkby, Nadine Hoffmann, Rehannah Borup, Søren Molin, Niels Høiby, Oana Ciofu.   

Abstract

Phenotypic and genotypic diversifications of Pseudomonas aeruginosa in the airways of patients with cystic fibrosis (CF) promote long-term survival of bacteria during chronic lung infection. Twelve clonally related, sequential mucoid and non-mucoid paired P. aeruginosa isolates obtained from three Danish CF patients were investigated. The in vitro biofilm formation capacity was studied under static and flow through conditions and the global gene expression profiles were investigated by Affymetrix GeneChip. Regulatory genes of alginate production and quorum sensing (QS) system were sequenced and measurements of the alginate production and the detection of the QS signal molecules were performed. Comparisons of mucoid and non-mucoid isolates from early and late stages of the infection showed that the mucoid phenotype maintained over a decade the capacity to form in vitro biofilm and showed an unaltered transcriptional profile, whereas substantial alterations in the transcriptional profiles and loss of the capacity to form in vitro biofilms were observed in corresponding isolates of the non-mucoid phenotype. The conserved gene expression pattern in the mucoid isolates vs the diversity of changes in non-mucoid isolates observed in this particular P. aeruginosa clone reflects different adaptation strategies used by these two phenotypes in the different niches of the CF lung environment.
© 2011 The Authors. APMIS © 2011 APMIS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21492226     DOI: 10.1111/j.1600-0463.2011.02726.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  22 in total

Review 1.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

Review 2.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

Review 3.  Bacterial Extracellular Polysaccharides in Biofilm Formation and Function.

Authors:  Dominique H Limoli; Christopher J Jones; Daniel J Wozniak
Journal:  Microbiol Spectr       Date:  2015-06

4.  Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.

Authors:  Evida A Dennis; Mamie T Coats; Sarah Griffin; Bing Pang; David E Briles; Marilyn J Crain; W Edward Swords
Journal:  Pathog Dis       Date:  2018-10-01       Impact factor: 3.166

5.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infections.

Authors:  Charles C Traverse; Leslie M Mayo-Smith; Steffen R Poltak; Vaughn S Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-27       Impact factor: 11.205

7.  Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Authors:  Kasper N Kragh; Morten Alhede; Peter Ø Jensen; Claus Moser; Thomas Scheike; Carsten S Jacobsen; Steen Seier Poulsen; Steffen Robert Eickhardt-Sørensen; Hannah Trøstrup; Lars Christoffersen; Hans-Petter Hougen; Lars F Rickelt; Michael Kühl; Niels Høiby; Thomas Bjarnsholt
Journal:  Infect Immun       Date:  2014-08-11       Impact factor: 3.441

8.  Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection.

Authors:  L J Christophersen; H Trøstrup; D S Malling Damlund; T Bjarnsholt; K Thomsen; P Ø Jensen; H P Hougen; N Høiby; C Moser
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

Review 9.  Cyclic di-GMP: the first 25 years of a universal bacterial second messenger.

Authors:  Ute Römling; Michael Y Galperin; Mark Gomelsky
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

10.  A quadruple knockout of lasIR and rhlIR of Pseudomonas aeruginosa PAO1 that retains wild-type twitching motility has equivalent infectivity and persistence to PAO1 in a mouse model of lung infection.

Authors:  James J Lazenby; Phoebe E Griffin; Jennelle Kyd; Cynthia B Whitchurch; Margaret A Cooley
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.